| US Masters Residential Property Fund (URF) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$221 |
Update - Notification of buy-back - URF
|
31 Jul 2024 9:03AM |
$0.305 |
$0.320 |
risen by
4.92%
|
|
| BlinkLab Limited (BB1) ORDINARY FULLY PAID |
Health Care |
$41 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2024 9:03AM |
$0.260 |
$0.475 |
risen by
82.69%
|
|
BB1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Initiated regulatory strategy assessment for US and EU device registration
- Started autism clinical study in partnership with Turning Pointe Autism Foundation
- Partnered with Erasmus University Medical Centre to evaluate AI-powered test for FTD and AD
- Commenced clinical study with Bates College to validate smartphone-based platform for Functional Neurological Disorder
- Initiated a new study in children aged 5-16 to validate diagnostic accuracy for ADHD
- Rolled-out major software updates for BlinkLab diagnostic application ahead of US clinical studies
- As of 30 June 2024, cash balance was $6.017 million
- Net cash used in operations was $0.966 million for the extended quarter ending 30 June 2024
- Financial updates show reduced cash outflows expected for the quarter ending 30 September 2024
- Completion of a 280 patient study in autism with results submitted for publication
- Additional clinical studies initiated for ADHD, autism, frontotemporal dementia, Alzheimer's disease, and functional neurological disorder
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$25 |
Further Significant Improvement in Rett Syndrome Patients
|
31 Jul 2024 9:02AM |
$0.070 |
$0.024 |
fallen by
65.71%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Further significant clinical improvements observed in Rett Syndrome patients after 20 weeks of NTI164 treatment.
- 100% of patients showed improvement with 57% 'very much/much improved'.
- Gold standard RSBQ measure showed a 24% improvement in Rett symptoms.
- No diarrhoea, vomiting/nausea reported from 12 to 20 weeks and no weight loss.
- Durable clinical response and excellent safety profile provide rationale for long-term NTI164 administration.
- Clinical improvement assessed using CGI-I showed statistically significant improvement in core domains.
- NTI164 treatment resulted in improvement in communication skills, mental alertness, socialisation/eye contact, and anxiety.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Firstwave Cloud Technology Limited (FCT) ORDINARY FULLY PAID |
Information Technology |
$29 |
Q4 FY24 Shareholder Update
|
31 Jul 2024 9:02AM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
FCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Q4 financial performance shows a slight decline in ARR and revenue, with gross profit remaining stable.
- Closing cash position for Q4 is $1.68m, with cash usage of $1.82m in Q4.
- No R&D tax offset income received, and high cash usage due to seasonal factors.
- Company has sufficient cash to operate until the end of Q3 FY25 without new sales.
- CEO Danny Maher reports targeting cashflow breakeven for FY25 and managing cash responsibly.
- Q4 sales update includes significant sales to the Australian Government and other clients.
- Strategic focus includes extending the partnership with Telstra and investing in North America and LATAM markets.
- Restructuring of the Sales & Marketing team following the departure of the CRO.
- LATAM regional focus under Omar Vadillo with a strong industry network and experience.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| A1 Investments & Resources Ltd (AYI) ORDINARY FULLY PAID |
Financials |
$21 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2024 9:02AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Oakajee Corporation Limited (OKJ) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities and Cashflow Report
|
31 Jul 2024 9:01AM |
$0.012 |
$0.058 |
risen by
383.33%
|
|
OKJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued regional exploration at Paynes Find project.
- Identified a 400m wide zone of anomalous gold mineralization in Paynes Find south.
- Associated elements include arsenic, bismuth, cobalt, copper, and tungsten.
- Mineralized zone open to the south beneath alluvial cover.
- Plans for additional AC drilling to define extent of gold mineralization.
- Infill angled overlapping AC drilling to locate high-grade gold zones.
- Financial position included $1,434,537 in liquid assets at quarter end.
- Held $682,537 in cash and $752,000 in shares of listed entities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| SSH Group Ltd (SSH) ORDINARY FULLY PAID |
Industrials |
$12 |
KMH Acquisition Term Loan Repaid Early
|
31 Jul 2024 9:01AM |
$0.070 |
$0.145 |
risen by
107.14%
|
|
SSH - Price-sensitive ASX Announcement
Full Release
Key Points
- SSH Group Ltd announced the early repayment of the KMH Acquisition Term Loan.
- The early repayment was authorized and carried out by SSH Group Ltd.
- Forward-looking statements were included in the announcement.
- Further details can be found on SSH Group's ASX page.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TURNERS AUTOMOTIVE GROUP LIMITED (TRA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$464 |
Turners 2024 Climate Related Disclosures
|
31 Jul 2024 9:01AM |
$4.480 |
$5.150 |
risen by
14.96%
|
|
| Avira Resources Ltd (AVW) ORDINARY FULLY PAID |
Materials |
$2 |
Quarterly Activities Report and Appendix 5B
|
31 Jul 2024 9:00AM |
$0.001 |
$0.007 |
risen by
600%
|
|
AVW - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Stage 2 Earn-in at Puolalaki Project, increasing interest to 51%
- Successful $805,000 oversubscribed placement
- Focus on Puolalaki Project with planned geophysical exploration and larger-scale drilling
- Surrender of non-core tenements in Western Australia
- Exploration expenditures included logistics, planning, geological mapping, and consulting fees
- Due diligence on Meru Copper-Gold Project concluded without proceeding
- Next steps involve reviewing historic gold potential at Puolalaki
- Significant gold mineralization identified during recent and historic drilling
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bellevue Gold Limited (BGL) ORDINARY FULLY PAID |
Materials |
$1,262 |
Bellevue Gold Project - Investor Site Visit
|
31 Jul 2024 9:00AM |
$1.330 |
$0.855 |
fallen by
35.71%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$54 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
31 Jul 2024 8:59AM |
$0.052 |
$0.072 |
risen by
38.46%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive cash flow for the quarter of US$3.1 million
- Cash balance as of 30 June 2024 was US$6.5 million
- Unaudited revenue of US$4.3 million for the quarter, up 8% from prior quarter
- Unaudited revenue of US$11.1 million for FY24, up 6% from FY23
- Services business revenue up 21% on Q3
- Cash receipts of US$7.4 million for the quarter
- Hologic fFN Development Agreement Phase 1 milestone achieved with US$0.4 million payment received
- Expansion of FebriDx distribution agreements with Henry Schein in Australia, New Zealand, and Belgium
- Launch of FebriDx in the US market with FDA clearance
- Development and IP agreements with Hologic valued at US$14.7 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dominion Minerals Limited (DLM) ORDINARY FULLY PAID |
Materials |
$7 |
Quarterly Activities Report and Cash Flow Report
|
31 Jul 2024 8:59AM |
$0.032 |
$0.032 |
fallen by
0%
|
|
| Firstwave Cloud Technology Limited (FCT) ORDINARY FULLY PAID |
Information Technology |
$29 |
FY24 Q4 Activity Report and Appendix 4C
|
31 Jul 2024 8:59AM |
$0.018 |
$0.017 |
fallen by
5.56%
|
|
FCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Extension of Telstra Product & Services Agreement (PSA) by 15 months until July 2025
- Contract extension and approximately 20% uplift for the largest CyberCision customer under Telstra PSA
- Formal confirmation by Telstra of end of service date for GPA firewall security on 30 June 2024 and CSX2 cloud infrastructure platform on 30 September 2024
- Reduction in ARR and ARGP due to end of GPA and CSX2 services
- Several new sales and contract renewals for Secure Traffic Management (STM) product through partners in Peru and Korea
- Appointment of new US-based Director Daniel Friel
- Cash position at the quarter end was $1.68 million, a decrease of $1.82 million from the previous quarter
- Annualised Recurring Revenue (ARR) of $10.06 million, a decrease of 3.9% quarter-on-quarter
- Revenue of $2.72 million, a decrease of 1.8% quarter-on-quarter
- Gross Profit in Q4 of $2.13 million, a decrease of 0.2% quarter-on-quarter
- Cash component of operational expenses was $2.43 million, a decrease of 18.7% quarter-on-quarter
- Capitalisation of development costs increased by 35.7% quarter-on-quarter to $0.76 million
- Net cash used in the quarter was $1.82 million
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$10 |
Positive results from AI-116 in vitro studies
|
31 Jul 2024 8:59AM |
$0.009 |
$0.006 |
fallen by
33.33%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- AI-116 significantly reduces glutamate-induced toxicity in vitro, exceeding Donepezil.
- Relative cell viability increased by 53% for AI-116 versus 17% for Donepezil in elevated glutamate.
- RNA sequencing identified 21 genes associated with dementia uniquely modulated by AI-116.
- Algorae filed an international Patent Cooperation Treaty (PCT) application for AI-116.
- Algorae has begun planning clinical trials for AI-116.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$63 |
Quarterly Activities and Cashflow Report
|
31 Jul 2024 8:58AM |
$0.012 |
$0.045 |
risen by
275%
|
|
AQD - Price-sensitive ASX Announcement
Full Release
Key Points
- Balladonia Project has identified potential for multiple mineralization styles including nickel, copper, iron-oxide copper-gold (IOCG), and Broken Hill Type (BHT) deposits.
- Gravity survey planned along the Tea Tree Trend to test for BHT deposits.
- Ground electromagnetic surveys planned to follow up bedrock conductors identified in the VTEM survey.
- Results from ground EM surveys will prioritize targets for future drilling.
- Morrisey Project is focusing on magnetite, nickel, copper, and platinum group elements (PGE).
- Plans for RC drilling to test for magnetic ultramafic rocks in the Latham Intrusion.
- Hamilton Project focuses on IOCG and BHT mineralization.
- Applications submitted to renew Exploration Licenses for the Hamilton Project.
- MT Davis Project involves VTEM Max survey to identify base metal targets.
- Cerro de Fierro Project in Peru shows continuity of copper mineralization.
- Drill permitting re-commenced at Lantana prospect, a high-priority porphyry copper target.
- Cangallo Project identified copper-gold porphyry system, permits in place for drilling.
- Playa Kali Project identified manto-style mineralization with potential for copper and gold.
- Parcoy Project in Peru seeks joint venture partner to explore copper targets.
- Company has $1.1 million in cash after investing $1.556 million in exploration.
- Received additional funds of $962,000 from South32 for work programs.
- Appendix 5B Cashflow Report included.
- Company's appeal against payments for State-Owned land access still pending.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Critical Minerals Group Limited (CMG) ORDINARY FULLY PAID |
Materials |
$14 |
Entitlement Offer to raise approximately $2.5 million
|
31 Jul 2024 8:58AM |
$0.150 |
$0.160 |
risen by
6.67%
|
|
CMG - Price-sensitive ASX Announcement
Full Release
Key Points
- CMG is undertaking a non-renounceable entitlement offer to raise approximately $2.5 million.
- The offer price is $0.15 per share, matching the closing price on 30 July 2024 and the theoretical ex-rights price.
- Eligible shareholders can subscribe for 3 new shares for every 10 existing shares held.
- The entitlement offer is fully underwritten by Morgans Corporate Limited, which is also the lead manager.
- Proceeds will fund the Lindfield Feasibility Study, pilot plant metallurgical testing, environmental studies, vanadium electrolyte business planning, and general working capital.
- Idemitsu Lindfield Pty Ltd, CMG's major shareholder, supports the offer and may increase its shareholding from 32.2% to 37.4%.
- Key dates include the announcement on 31 July 2024, ex-date on 2 August 2024, record date on 5 August 2024, and offer closing on 21 August 2024.
- Approximately 16,624,000 new shares will be issued.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Image Resources NL (IMA) ORDINARY FULLY PAID |
Materials |
$93 |
APPROVAL OF MINING PROPOSAL FOR ATLAS MINERAL SANDS PROJECT
|
31 Jul 2024 8:58AM |
$0.072 |
$0.083 |
risen by
15.28%
|
|
IMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Approval of the Mining Proposal for the Atlas mineral sands project
- Atlas project is 100% owned by Image Resources NL
- Atlas is located 170km north of Perth in the North Perth Basin
- The Department of Energy, Mines, Industry Regulation and Safety approved the proposal on 19 July 2024
- Commonwealth conditions for approval under the EPBC Act are under review
- Approvals for groundwater operating strategy, Offset Environmental Management Plan, and Banksia Woodlands Rehabilitation Environmental Management Plan are anticipated
- Construction at the Atlas site expected to begin in Q3 2024
- Managing Director and CEO Patrick Mutz commented on the progress and anticipated construction activities
- Early works camp construction and deconstruction of the Boonanarring WCP have started
- Project commissioning is aimed to start by the end of December 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VanEck Emerging Income Opportunities Active ETF (Managed Fund) (EBND) |
Financials |
$178 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$10.230 |
$10.650 |
risen by
4.11%
|
|
| VanEck Australian Banks ETF (MVB) |
Financials |
$240 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$36.550 |
$40.010 |
risen by
9.47%
|
|
| VanEck Bentham Global Capital Securities Active ETF (Managed Fund) (GCAP) |
Financials |
$32 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$8.800 |
$8.840 |
risen by
0.45%
|
|
| VanEck Australian Corporate Bond Plus ETF (PLUS) |
Financials |
$393 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$16.620 |
$17.220 |
risen by
3.61%
|
|
| VanEck Australian Subordinated Debt ETF (SUBD) |
Financials |
$2,538 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$25.250 |
$25.200 |
fallen by
0.20%
|
|
| VanEck 1-3 Month US Treasury Bond ETF (TBIL) |
Financials |
$140 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$51.230 |
$51.010 |
fallen by
0.43%
|
|
| VanEck Global Listed Private Credit (AUD Hedged) ETF (LEND) |
Financials |
$162 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$20.340 |
$19.580 |
fallen by
3.74%
|
|
| VanEck 5-10 Year Australian Government Bond ETF (5GOV) |
Financials |
$76 |
Final Dividend/Distribution for period ending 31 July 2024
|
31 Jul 2024 8:58AM |
$51.220 |
$52.890 |
risen by
3.26%
|
|
Call 1300 880 160
Start a chat
Schedule a call
